News

Unnatural Products, Inc. (UNP), a biotechnology company focused on developing orally delivered macrocyclic peptides for hard-to-drug targets, has entered into a research collaboration…
Read More...

Scribe Therapeutics, Inc. has achieved a second success milestone in its ongoing collaboration with Eli Lilly and Company, marking further progress in the development of in vivo…
Read More...

Teijin Pharma Limited has signed a joint research agreement with Aska Pharmaceutical Co., Ltd. to develop new small-molecule drug candidates for gynecological diseases, marking a…
Read More...

Immunic, Inc. announced it has priced a private placement expected to generate up to $400 million in gross proceeds, funding the company’s shift from a research-focused biotech to a…
Read More...

Disc Medicine said the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for its New Drug Application seeking approval of bitopertin to treat erythropoietic…
Read More...

PTC Therapeutics has withdrawn its resubmitted New Drug Application for Translarna (ataluren) to treat nonsense mutation Duchenne muscular dystrophy after receiving review feedback from…
Read More...

China-based biotech developer Shanghai Ark Biopharmaceutical Co., Ltd. has received clearance from the U.S. Food and Drug Administration to begin a U.S. clinical study of its…
Read More...

French pharmaceutical group Sanofi announced a leadership transition after its board decided not to renew the mandate of Chief Executive Officer Paul Hudson. His final day leading the…
Read More...

Biotechnology company Amgen has received authorization from the European Commission for UPLIZNA as an add-on therapy for adults with generalized myasthenia gravis (gMG) who test…
Read More...

Pharmaceutical giant Merck & Co., Inc. — known internationally as MSD — has received U.S. regulatory approval for expanded use of its immunotherapy KEYTRUDA and the newer…
Read More...

Cancer-focused biotechnology company Citius Oncology, Inc. has entered an exclusive distribution agreement with international healthcare services group Uniphar to expand patient access…
Read More...

Biopharmaceutical company Madrigal Pharmaceuticals, Inc. has signed an exclusive global licensing agreement with Suzhou Ribo Life Science Co. Ltd. and its subsidiary Ribocure…
Read More...

Private equity firm Ampersand Capital Partners has announced the acquisition of contract development and manufacturing provider Purna Pharmaceuticals, signaling a strategic move to…
Read More...

A new collaboration between U.S. cell-therapy manufacturer Kincell Bio and biotechnology innovator RegCell aims to accelerate the clinical development of a next-generation…
Read More...

Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical System Holdings have announced a multi-project collaboration aimed at…
Read More...

Biotechnology company Moderna, Inc. said the FDA Center for Biologics Evaluation and Research has refused to begin reviewing its biologics license application for the investigational…
Read More...

Biotechnology company Moderna, Inc. has signed a five-year strategic memorandum of understanding with the Government of Mexico, state manufacturer BIRMEX and pharmaceutical firm…
Read More...

Takeda has entered a multi-year collaboration with clinical-stage biotechnology company Iambic aimed at accelerating the development of new medicines using artificial…
Read More...

Takeda has taken a major step toward introducing a novel treatment for narcolepsy type 1 after the U.S. Food and Drug Administration accepted its New Drug Application and granted…
Read More...

REGENXBIO Inc. has received a setback in its efforts to bring a gene therapy to patients with Hunter syndrome, after the U.S. Food and Drug Administration (FDA) issued a Complete…
Read More...